BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6611366)

  • 1. Antigen presentation by the BCL1 murine B cell line: in vitro stimulation by LPS.
    Harris MR; Kindle CS; Abruzzini AF; Pierce CW; Cullen SE
    J Immunol; 1984 Sep; 133(3):1202-8. PubMed ID: 6611366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN
    J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IA mutant functional antigen-presenting cell lines.
    Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
    J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mediated leukemogenesis: murine leukemia virus interacts with BCL1 lymphoma cell surface IgM.
    McGrath MS; Tamura G; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):227-42. PubMed ID: 2855408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of differentiation in a B lymphoma X B lymphocyte hybrid line. II. Intraclonal heterogeneity in growth, secretion of IgM, and cytokine production in response to lipopolysaccharide.
    Little J; Alling DW; Asofsky R
    J Immunol; 1993 Mar; 150(6):2129-38. PubMed ID: 8450206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.
    Knapp MR; Severinson-Gronowicz E; Schröder J; Strober S
    J Immunol; 1979 Sep; 123(3):1000-6. PubMed ID: 381513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
    Knapp MR; Jones PP; Black SJ; Vitetta ES; Slavin S; Strober S
    J Immunol; 1979 Sep; 123(3):992-9. PubMed ID: 313960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-induced differentiation of a murine B cell leukemia (BCL1): changes in surface and secreted IgM.
    Lafrenz D; Koretz S; Stratte PT; Ward RB; Strober S
    J Immunol; 1982 Sep; 129(3):1329-35. PubMed ID: 6980922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
    Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
    J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.
    O'Neill HC; Ni K
    Immunology; 1993 Jun; 79(2):220-8. PubMed ID: 8344701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of accessory cells in B cell responses to thymus-independent antigens.
    Sinha AA; Guidos C; Lee KC; Diener E
    J Immunol; 1987 Jun; 138(12):4143-9. PubMed ID: 3495580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen-derived stromal cells. Adhesion molecules expression and lymphocyte adhesion to reticular cells.
    Castro A; Bono MR; Simon V; Vargas L; Rosemblatt M
    Eur J Cell Biol; 1997 Dec; 74(4):321-8. PubMed ID: 9438127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
    Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
    J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
    George AJ; Spellerberg MB; Stevenson FK
    J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
    Lopez DM; Charyulu V; Paul RD
    J Immunol; 1985 Jan; 134(1):603-7. PubMed ID: 2981095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of cells controlling H-2-restricted presentation of antigen to T helper cells in vivo.
    Sprent J
    J Immunol; 1980 Nov; 125(5):2089-96. PubMed ID: 6968772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.